For Patients Caregiver Tips and Advice For Medical Professionals

ALF Research Awards Program

Research is integral to the work of the American Liver Foundation and is essential to improving, treating and finding a cure for liver disease.

Since 1979, the Research Awards Program has provided more than $26 million in research funding. Over 850 qualified scientists and physicians have pursued careers in liver disease research and treatment as a result of receiving these grants early in their careers.

The American Liver Foundation is proud to support these research efforts and is hopeful that they will bring us closer to finding a cure for liver disease.

Contact us here for any questions about these research awards.


ALF Research Awards Program

Are there any funding opportunities for pre-doctoral students at the American Liver Foundation?

Currently there are no funding opportunities for pre-doctoral students.

 


Must my project focus on basic science? Can I submit a project focused on clinical studies?

Either basic science or clinical studies are eligible for funding.

 


My fellowship program is 3 year program but my second and third years are dedicated to research training. I am currently in my 3rd year of the program. Does this make me ineligible for the Postdoctoral Award?

The amount of years of actual research training is counted, so you are still eligible.

 


One of our transplant doctors is interested in submitting for a Liver Scholar Award however his salary is already covered so he would like to hire a tech and purchase supplies instead of using the award solely for his salary support. Would that be acceptable?

No, the Liver Scholar Award must be used for salary support only.

 


Can I apply for both a Liver Scholar Award and a Postdoctoral Research Fellowship Award?

No, you must apply for one or the other.

 


I am a faculty member but my job title is Postdoctoral Associate. Prior to this appointment, I was a post-doctoral fellow for 2 years. Am I still eligible for a Liver Scholar Award?

If you are a faculty member then you can apply. Clearly state in your commitment letter from your department chair that you have a faculty appointment.

Naim Alkhouri, MD
Nonalcoholic fatty liver disease, hepatitis C infection, liver transplantation, pediatric liver disease

Jasmohan S. Bajaj, MD, MS, FACG, AGAF (co-chair)
Cirrhosis and complications

David N. Frick, PhD
Viral Hepatitis (Virology in General), Enzymology, Molecular Genetics, Structural Biology, and Genomics

Richard M. Green, MD
Cholestatic and fatty liver disease-clinical, cholestatic and fatty liver disease-basic science

Rohit Loomba, MD, MHSc (co-chair)
Nonalcoholic fatty liver disease, advanced imaging, steatosis and its effect of progression of liver disease

Pramod Mistry, MD, BS, FRCP, PhD
Metabolic liver disease (inherited and NAFLD); Liver transplantation; Pediatric liver diseases

Michael Porayko, MD, FAASLD
Cholestatic liver disease, viral hepatitis B and C, autoimmune hepatitis, acute liver failure, nutritional abnormalities of chronic liver disease and multiple complications of chronic liver failure including hepatorenal syndrome as well as liver transplantation related topics (e.g immunosuppression, complications, recurrent disease, allograft rejection)

Puneet Puri, MD
NAFLD, alcoholic liver disease, cirrhosis and its complications, nutrition in liver disease, lipidomics, metabolomics and microbiome related

Jayanta Roy-Chowdhury, MBBS, MRCP
Inherited disorders of the liver, stem cell differentiation, hepatocyte transplantation, liver-directed gene therapy

Li Wang, PhD
Broad expertise in various liver diseases, including fatty liver (non-alchol and alcohol), NASH, lipid metabolism, cholestasis, bile acid, liver fibrosis, liver cancer, non-coding RNA (microRNA and lncRNA) etc.

David Q.H. Wang, MD, PhD
Gallstones, Alcoholic fatty liver disease, nonalcoholic fatty liver disease, cholestasis; hepatic bile acid and cholesterol metabolism, intestinal absorption of cholesterol and fatty acids.

Phillip Hylemon, PhD
Bile acid signaling in the liver and regulation of nutrient metabolism; human gut microbiome and GI/Liver diseases, cholangiocytes and cholangiocarcinoma

David E. Cohen, MD, PhD
Lipids, Lipoproteins, Bile Acids, Fatty Liver and Obesity

Ekihiro Seki, MD, PhD
Toll-like receptor and cytokine signaling, Liver fibrosis, non-alcoholic steatohepatitis and alcoholic liver disease

Bernd Schnabl, MD
Basic hepatology research including liver fibrosis, NAFLD/NASH, ALD and microbiome

Rohit Kohli, MBBS, MS
Pediatric hepatology, NASH, transplant hepatology

Yaron Rotman, MD, MSc
Non-alcoholic fatty liver disease (clinical and basic), genetics, hepatitis C, interferon signaling

Theo Heller, MD
Liver disease, especially non cirrhotic portal hypertension, portal hypertension, viral hepatitis, ciliopathies, and translational aspects of all of these as well as an increasing interest in the microbiome and how it relates to liver disease

Kari N. Nejak-Bowen, MBA, PhD
Experimental cholestasis, liver regeneration (initiation, proliferation, termination), and the beta-catenin signaling pathway in liver physiology and pathobiology

Nancy S. Reau, MD
Liver Diseases (Hepatology) Nonalcoholic steatohepatitis, Liver transplantation, Hepatitis B virus, Hepatitis C virus, Primary liver cancer

Harmeet Malhi, MBBS
Liver injury (esp NASH), Macrophage mediated liver injury, Liver inflammation (NASH), Endoplasmic reticulum stress, Apoptosis, Extracellular vesicles

Natalie J. Torok, MD, MSc, AGAF
Liver fibrosis, NASH, oxidative stress, fibrosis treatment (trials), apoptosis, alcoholic liver disease

Amir Zarrinpar, MD, PhD
NAFLD/NASH, Obesity, metabolic syndrome, type 2 diabetes mellitus, microbiome, microRNAs, bile acid signaling (FXR/TGR5), circadian rhythms, metabolism

Huiping Zhou, PhD
Bile acids and hepatic lipid metabolism, Sphingosine-1 phosphate and GPCR signaling, NAFLD/NASH, Cholestasis, Cholangiocarcinoma, ER stress, alcohol and drug-induced liver injury, Inflammation, bile acid metabolism and microbiome, alternative and complementary medicine

Wajahat Mehal, MD, DPhil
Immunology, inflammation, NASH, fibrosis

Ariel Feldstein, MD
NASH; liver fibrosis; basic mechanism of liver inflammation and injury; HCC

Don C. Rockey, MD
Basic, Fibrosis, Cirrhosis, Portal Hypertension, Vascular Biology, Cell Biology, Molecular Biology, Clinical, Cirrhosis, Drug induced liver injury, outcomes

Vipin Kumar, MS, PhD
CD8+ Treg/CD8+ suppressor cells, LPC-reactive type II NKT cells, autoimmune and inflammatory diseases, anti-tumor immunity, ALD, NASH, type I and type II NKT cells

Laura E. Nagy, PhD
Alcoholic and non-alcoholic liver disease, innate immunity  and cell death

Chandrashekhar Gandhi, PhD, FAASLD
Liver fibrosis, Acute liver injury, Alcoholic and nonalcoholic steatohepatitis, hepatic stellate cells.

Yury Popov, MD, PhD
Liver fibrosis, cirrhosis, fibrosis reversal, antifibrotic therapies, animal models, integrins, hepatic stellate cells, hepatic progenitor cells, cholangiocytes, collagens, cross-linking, extracellular matrix.

Keith D. Lindor, MD
Cholestatic liver diseases, particularly primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).

Hugo E. Vargas, MD
Management of HCV and HBV in Transplantation; Portal Hypertension Management; Alcoholic Liver Disease

Alan Mullen, MD, PhD
Liver fibrosis, chronic liver disease; viral hepatitis; abnormal liver function tests, NAFLD; noncoding RNA regulation of hepatic stellate cells

Kusum Kharbanda, Ph.D
Alcoholic Liver Disease

Shikha Sundaram, MD, MSCI
Pediatric liver disease, pediatric liver transplant and pediatric non-alcoholic fatty liver disease.


Research Award Recipients


American Liver Foundation Liver Scholar Award
$75,000 annually/3 years; $225,000 total

Xiaobo Wang, PhD
Columbia University

Project: “Regulation and Role of TAZ in NASH-Associated Hepatocellular Carcinoma”
Mentor: Ira A. Tabas, MD, PhD

Click more to learn more about Dr. Wang and his research project


American Liver Foundation PBC Fund for the Cure Award
$
100,000 over 1 year

Marina Silveira, MD
Yale University

Project: “Mindfulness-Based Stress Reduction in the Treatment of Fatigue in Patients with PBC”

Click Here to learn more about Dr. Silveira and her research project

Weici Zhang, PhD
University of California, Davis

Project: “IGFBP4 Expression Licenses Macrophage Immune-Mediated Biliary Destruction in PBC”

Click here to learn more about Dr. Weici Zhang and her research project


American Liver Foundation Postdoctoral Research Fellowship Awards
$
12,500 over 1 year

Irwin M. Arias, MD Postdoctoral Research Fellowship

Norihiro Imai, MD, PhD
Joan & Sanford I. Weill Medical College of Cornell University

Project: “Muscle-Specific Metabolic Regulation by Thioesterase Superfamily Member 2 (Them2) in the Pathogenesis of Nonalcoholic Fatty Liver Disease”
Mentor:  David E. Cohen, MD, PhD

Click here to learn more about Imai and his research

Hans Popper Memorial Postdoctoral Research Fellowship

Aveline Filliol, PhD
The Trustees of Columbia University in the City of New York

Project: “Role of HSC and ECM in the Development of Hepatocellular Carcinoma”
Mentor: Robert F. Schwabe, MD

Click here to learn more about Dr. Aveline Filliol and her research

Sandra Steensels, PhD
Joan & Sanford I. Weill Medical College of Cornell University

Project: “Thioesterase-mediated Control of Hepatic Lipid and Glucose Homeostasis”
Mentor: Baran A. Ersoy, PhD

Click here to learn more about Dr. Steensels and her research

James Heslop, PhD
Medical University of South Carolina

Project: “The Role of GATA6 in Endoderm Formation and Hepatic Specification”
Mentor: Stephen A. Duncan

Click here to learn more about Dr. Heslop and his research

American Liver Foundation Liver Scholar Award
$75,000 annually/3 years; $225,000 total

Graham Brady, MD, PhD
University of Michigan

Role of the nuclear lamina in nonalcoholic fatty liver disease
Mentor: M. Bishr Omary, MD, PhD

American Liver Foundation Postdoctoral Fellowship Research Award Winners
$12,500 over 1 year

Yongfeng Song, MD, PhD
University of Connecticut

ZEB1/EpCAM Axis in LncRNA H19-Mediated Cholestasis
Mentor: Li Wang, PhD

Mariana L. Acuña, PhD
Cornell University

ACOT12-Mediated Acetyl-CoA Degradation in the Pathogenesis of Non-Alcoholic Fatty Liver Disease
Mentor: David E. Cohen, MD, PhD

Enis Kostallari, PhD
Mayo Clinic

PDGFR-alpha trafficking through hepatic stellate cell-derived extracellular vesicles
Mentor: Vijay H. Shah, MD

Paul J. Wrighton, PhD
Brigham and Women’s Hospital / Harvard Medical School

How Liver Stiffness Promotes Liver Cancer
Mentor: Wolfram Goessling, MD, PhD

Kazuki Takeshi, MD, PhD
University of Pittsburgh

Mass Production of iPS-derived Hepatocytes to engineer Autologous Liver Graft
Mentor: Alejandro Soto-Gutierrez, MD, PhD

Ruisi (Rose) Wang, PhD
The Rockefeller University

Novel stem cell approaches to explore hepatic stellate cell biology
Mentor: Charles M. Rice, PhD

Liuyi Hao, PhD
University of North Carolina at Greensboro

The role of ATF4 in alcoholic hepatitis
Mentor: Zhanxiang Zhou, PhD

Barent N. DuBois, PhD
Chapman University School of Pharmacy

Effect of acute-on-chronic liver failure on drug metabolism in the brain.
Mentor: Reza Mehvar, PharmD, PhD

Chun-Hao Huang, PhD
The Regents of the University of California, Berkeley

Understanding cellular immune response to viral translation during liver damage
Mentor: Jennifer A. Doudna, PhD

Wei Wang, MD
New York University School of Medicine

Role of gamma delta-T cells in the pathogenesis of NASH
Mentor: George Miller, MD


American Liver Foundation Liver Scholar Award
$75,000 annually/3 years; $225,000 total

Hepatitis Fund for the Cure Liver Scholar Award

Holly Ramage, PhD
University of Pennsylvania

Characterizing the Role of Host Cell Ubiquitylation Machinery in HCV Infection
Mentor: Sara R. Cherry, PhD


American Liver Foundation Postdoctoral Fellowship Awards
$12,000 over 1 year

NASH Fatty Liver Disease Postdoctoral Research Fellowship

Michele Alves-Bezerra, PhD
Weill Cornell Medicine

Phospholipid-mediated control of hepatic insulin signaling
Mentor: David E. Cohen, MD, PhD

Herman Lopata Memorial Hepatitis Postdoctoral Research Fellowship

Joshua A. Jackman, PhD
Stanford University School of Medicine

Engineering Platform for Deciphering Inositol-Binding Domains in Hepatitis C Virus
Mentor: Jeffrey S. Glenn, MD, PhD

Thomas E. Starzl, MD Postdoctoral Research Fellowship

Negin Karimian, MD, PhD
Massachusetts General Hospital / Harvard Medical School

A Novel Approach to Improve Organ Viability and Availability before Orthotopic Liver Transplantation
Mentor: Korkut Uygun, PhD

Charles Trey, MD Memorial Postdoctoral Research Fellowship

Chad M. Walesky, PhD
Brigham and Women’s Hospital / Harvard Medical School

A Balancing Act: Role of HNF4α/β-catenin in Hepatobiliary Development and Cholangiocarcinoma Formation
Mentor:  Wolfram Goessling, MD, PhD

Hans Popper Memorial Postdoctoral Research Fellowship

Ju Dong Yang, MD
Mayo Clinic College of Medicine

Detection of Actionable or Predictive Tumor DNA Mutations in Peripheral Blood (Liquid Biopsy) from Patients with Cholangiocarcinoma (CCA)
Mentor:  Lewis R. Roberts, PhD

Irwin M. Arias, MD Postdoctoral Research Fellowship

Janice E. Yang, PhD
Cedars-Sinai Medical Center

The role of hyaluronan synthase-2 in the pathogenesis of Liver Fibrosis
Mentor:  Ekihiro Seki, MD, PhD

Thomas F. Nealon, III Postdoctoral Research Fellowship Honoring Zachary Rue

Anna L. Peters, MD, PhD
Cincinnati Children’s Hospital Medical Center

Control of cholangiocyte proliferation by innate lymphoid cells
Mentor:  Jorge A. Bezerra, MD

Congressman John Joseph Moakley Postdoctoral Research Fellowship

Regina Español-Suñer, PhD
University of California, San Francisco

In vivo reprogramming of scar tissue into hepatocytes as a therapy for liver fibrosis
Mentor:  Holger Willenbring, MD, PhD

PSC Postdoctoral Research Fellowship

Ana Catalina Arce-Clachar, MD
Cincinnati Children’s Hospital Medical Center

The role of TGR5 signaling in the pathogenesis of murine fibrosing cholangitis and its response to pharmacological inhibition of intestinal bile acid reuptake
Mentor:  Alexander Miethke, MD

Roger L. Jenkins, MD Postdoctoral Research Fellowship

Stephanie A. Kingman, MD
The Regents of the University of California, Los Angeles

Gene Therapy-Corrected Autologous Hepatocyte-Like Cells from Induced Pluripotent Stem Cells For the Treatment of Pediatric Single Enzyme Disorders
Mentor:  Gerald S. Lipshutz, MD


Distinguished Scientific Achievement Award

Dr. Arun Sanyal
Dr. Arun Sanyal is a Professor of Medicine, Physiology and Molecular Pathology at Virginia Commonwealth University School of Medicine in Richmond, Virginia. He has been a physician-scientist for 25 years and his research has spanned the spectrum of translational science from basic discovery to first in humans and advanced phase clinical trials and regulatory aspects of drug development. He has extensive experience and expertise in team science, and has recently further applied these to alcoholic liver disease and is leading several specific efforts in the National Institute on Alcohol Abuse and Alcoholism (NIAAA) funded TREAT consortium. He recently established the Liver Forum which provides a neutral platform for FDA, EMA and other stakeholders in fatty liver disorders to work collaboratively on the regulatory science required to accelerate drug development in liver disease. This further requires substantial consensus building and team science.

2017
Arun Sanyal, MD
Virginia Commonwealth University School of Medicine

2016
Scott L. Friedman, MD

Icahn School of Medicine at Mount Sinai

2015
Anna Suk-Fong Lok, MD

University of Michigan Health System

2014
Raymond Schinazi, PhD, DSc

Emory University, Center for AIDS Research

2013
Charles M. Rice, PhD

The Rockefeller University

2012
Allan W. Wolkoff, MD

Albert Einstein College of Medicine

2011
Robert H. Purcell, MD

National Institutes of Health

2010
George K. Michalopoulos, MD, PhD

University of Pittsburgh School of Medicine

2009
Snorri S. Thorgeisson, MD, PhD

National Cancer Institute

2008
Neil Kaplowitz, MD

University of Southern California School of Medicine

2006
Roberto J. Groszmann, MD

West Haven VA Medical Center

2004
Nelson Fausto, MD

University of Washington School of Medicine

2002
Harvey J. Alter, MD

National Institutes of Health

2001
Nancy L. Bucher, MD

Boston University School of Medicine

2000
David A. Shafritz, MD

Albert Einstein College of Medicine

1999
James L. Boyer, MD

Yale University

1998
Irwin M. Arias, MD

Tufts University School of Medicine

1997
Francis V. Chisari, MD

The Scripps Research Institute


Share this page
Facebooktwittergoogle_pluspinterestlinkedinmailFacebooktwittergoogle_pluspinterestlinkedinmail

Visit Us On FacebookVisit Us On TwitterVisit Us On InstagramVisit Us On YoutubeVisit Us On Linkedin